U
Ulrich Bogdahn
Researcher at University of Regensburg
Publications - 347
Citations - 36060
Ulrich Bogdahn is an academic researcher from University of Regensburg. The author has contributed to research in topics: Neural stem cell & Neurogenesis. The author has an hindex of 67, co-authored 344 publications receiving 32279 citations. Previous affiliations of Ulrich Bogdahn include Hoffmann-La Roche & Volkswagen Foundation.
Papers
More filters
Journal ArticleDOI
Can intraoperative clinical testing predict stimulation-induced effects of STN-DBS?
Biological activity of two botulinum toxin type A complexes (Dysport® and Botox®)
Kai Wohlfarth,Imke Schwandt,Florian Wegner,Tim Jürgens,Götz Gelbrich,Armin Wagner,Ulrich Bogdahn,Wilhelm J. Schulte-Mattler +7 more
TL;DR: In this article, a dose-ranging, electroneurographic study investigated the dose equivalence, diffusion characteristics (spread) and safety of these two type-A toxins in 79 volunteers.
Journal ArticleDOI
Lernbedingte transiente Strukturänderung im adulten Gehirn
Journal ArticleDOI
MUNIX – ein viel versprechender Biomarker bei der ALS
TL;DR: In this paper, a new MUNE-Verfahren is eingesetzt, i.e., motor unit number index (MUNIX), which is used for quantitativ quantification of the Verlust motorischer Nervenzellen bei the amyotrophen Lateralsklerose.
Journal ArticleDOI
Pseudoprogression after treatment with the TGF-beta 2 inhibitor trabedersen in high-grade glioma patients.
Ulrich Bogdahn,G. Stockhammer,Ashok Kumar Mahapatra,N. K. Venkataramana,V. E. Oliushine,V. E. Parfenov,I. E. Poverennova,P. Jachimczak,H. Heinrichs,Karl-Hermann Schlingensiepen +9 more
TL;DR: Pseudoprogression has frequently been described in high-grade glioma patients after chemoradiotherapy with temozolomide (TMZ) and Trabedersen (AP 12009), a TGF-beta 2 spe...